Aveanna Healthcare Holdings's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 45.89.
Aveanna Healthcare Holdings's Days Inventory for the
three
months ended in Mar. 2026 was 0.
Aveanna Healthcare Holdings's Days Payable for the
three
months ended in Mar. 2026 was 6.84.
Therefore, Aveanna Healthcare Holdings's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 39.05.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Aveanna Healthcare Holdings Cash Conversion Cycle Related Terms
Aveanna Healthcare Holdings Cash Conversion Cycle Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVAH vs AGL, SNDA, HCSG: Cash Conversion Cycle Comparison
For the Medical Care Facilities subindustry, Aveanna Healthcare Holdings's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aveanna Healthcare Holdings Cash Conversion Cycle vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aveanna Healthcare Holdings's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Aveanna Healthcare Holdings's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Aveanna Healthcare Holdings's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aveanna Healthcare Holdings (AVAH) has a Cash Conversion Cycle of 39.05 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Aveanna Healthcare Holdings and its competitors.
Is Aveanna Healthcare Holdings' Cash Conversion Cycle too high?
Aveanna Healthcare Holdings' current Cash Conversion Cycle is 39.05. The Healthcare Providers & Services industry median Cash Conversion Cycle is 18.32. Aveanna Healthcare Holdings' value of 39.05 is 113.2% above this industry median. Overall, Aveanna Healthcare Holdings has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aveanna Healthcare Holdings' Cash Conversion Cycle compare to AGL and SNDA?
Aveanna Healthcare Holdings' Cash Conversion Cycle of 39.05 can be compared against companies in the Healthcare Providers & Services industry. The industry median Cash Conversion Cycle is 18.32. Aveanna Healthcare Holdings' value of 39.05 is 113.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Healthcare Providers & Services company?
The median Cash Conversion Cycle among Healthcare Providers & Services companies is 18.32, based on 667 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aveanna Healthcare Holdings's current Cash Conversion Cycle of 39.05 is 113.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Aveanna Healthcare Holdings and its competitors. For the Healthcare Providers & Services industry, the median Cash Conversion Cycle is 18.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aveanna Healthcare Holdings's current Cash Conversion Cycle is 39.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aveanna Healthcare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings (AVAH) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.16, compared to a current price of $8.66 — trading 67.8% above its estimated fair value. The current Cash Conversion Cycle is 39.05 and 113.2% above the Healthcare Providers & Services industry median of 18.32. Aveanna Healthcare Holdings' overall GF Score™ is 69/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Aveanna Healthcare Holdings (AVAH), the current Cash Conversion Cycle is 39.05 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aveanna Healthcare Holdings (AVAH) Overvalued in 2026?
Based on GuruFocus' analysis, Aveanna Healthcare Holdings stock appears to be overvalued.
The current stock price of $8.66 is trading 67.8% above its estimated GF Value™ of $5.16.
GuruFocus considers Aveanna Healthcare Holdings to be Significantly Overvalued.
Key valuation signals for AVAH:
Cash Conversion Cycle: 39.05
GF Value™: $5.16 vs. price of $8.66 (67.8% above fair value)
Industry Position: 113.2% above the Healthcare Providers & Services median
No single metric tells the full story. See the AVAH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
69GF Score
Get the complete analysis for AVAH
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVAH has been successfully added to your 
